---
title: CDMOs offering Biologics Development & Manufacturing with Vaccine
path: /explore/biologics-development-manufacturing/vaccine
companies_count: 14
---

# CDMOs offering Biologics Development & Manufacturing with Vaccine

14 published CDMOs match Biologics Development & Manufacturing and Vaccine.

Locations in this set include United States, China, United Kingdom, Germany, India, and Japan.

Capabilities that show up most often in this set: Vaccine Manufacturing, CMC Analytical Development, Monoclonal Antibody (mAb) Manufacturing, Process Development, and Recombinant Protein Manufacturing.

## Matching companies

- [Ascend](/companies/ascend-adv)
  - Ascend is a gene-to-GMP development partner specializing in advanced biologics and vaccines with 60+ years of custom biologics expertise and 20+ years of AAV development capability. The company offers onsite fill-finish capabilities across multiple US locations and combines next-generation technologies with deep regulatory acumen.
- [Bharat Biotech](/companies/bharatbiotech)
  - Bharat Biotech is a pioneering biotechnology company specializing in vaccines and bio-therapeutics manufacturing.
- [Cytovance Biologics](/companies/cytovance-biologics)
  - U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.
- [FUJIFILM Biotechnologies](/companies/fujifilm-biotechnologies)
  - CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.
- [Grand River Aseptic Manufacturing](/companies/grandriverasepticmfg)
  - Sterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines.
- [National Resilience](/companies/resilience)
  - End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions)
  - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- [ProBioGen AG](/companies/probiogen)
  - ProBioGen AG is a CDMO offering cell line development, process development, GMP manufacturing and analytical services for proteins, antibodies, viral vectors and vaccines. It also provides technology platforms for biopharmaceutical manufacturing.
- [Samsung Biologics](/companies/samsungbiologics)
  - Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
- [Simtra BioPharma Solutions](/companies/simtra-biopharma-solutions)
  - Simtra BioPharma Solutions is a CDMO specializing in sterile injectable development and manufacturing, including formulation, lyophilization, fill/finish, and bioconjugation services for clinical and commercial products.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [WuXi Vaccines](/companies/wuxivaccines)
  - Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.
- [Yapan Bio](/companies/yapan-bio)
  - Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.